SUPANSA KITJAROEN: Open Payments
NPI 1881203495 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 8 payments from 6 companies in 2025. Trend: 2023 $208 · 2024 $90 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $123 |
| Vifor Pharma, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Veloxis Pharmaceuticals, Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
Products named: Ozempic, THYMOGLOBULIN, Veltassa, LIVTENCITY, ENVARSUS, ULTOMIRIS.
Industry payments across VA — which companies pay providers there.
